Phase I study of pomalidomide in relapsed or refractory Waldenstrom macroglobulinemia
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 25 Aug 2017
At a glance
- Drugs Pomalidomide (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Adverse reactions
- 18 Aug 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2019.
- 18 Aug 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Oct 2019.
- 17 Jun 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History